Often called the silent thief of sight, glaucoma is a group of eye diseases that gradually damage the optic nerve, often ...

Shared insight on how the use and sequencing of therapies for glaucoma will evolve in coming years. Neil Minkoff, MD: Where do we see glaucoma therapy going in the next 24 to 36 months, due to ...

Add Yahoo as a preferred source to see more of our stories on Google. “The term glaucoma refers to a group of diseases that cause permanent damage to the optic nerve, which is the cable that connects ...

Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery with a twice-a-year injection to control the buildup of pressure in the ...

Supplementation with vitamin B3 is associated with a 66% lower risk of developing glaucoma in people with high eye pressure, a real-world study shows.

Glaucoma causes vision loss by damaging the optic nerve. This leads to loss of peripheral vision and eventually blindness. The damage to the optic nerve is multifactorial, but increased ocular ...

This story is part of a series on the current progression in Regenerative Medicine. This piece is part of a series dedicated to the eye and improvements in restoring vision. In 1999, I defined ...

Glaucoma and Cataract are two distinct diseases of the eye but are often confused due to similar terminology of motia in ...

Glaucoma is the leading cause of irreversible visual impairment worldwide. Because the disease often progresses without ...

Looking back, glaucoma specialists like Dr. Christine Funke of Barnet Dulaney Perkins Eye Center can remember a time not long ago when treatment options for the eye condition were greatly limited.

This medical stock is in the buy zone of a base. The glaucoma treatment developer raised its revenue forecast in its latest ...

Researchers have developed a potential new treatment for the eye disease glaucoma that could replace daily eye drops and surgery with a twice-a-year injection to control the buildup of pressure in the ...